Drug Shortage Report for HP-PAC

Last updated on 2018-06-26 History
Report ID 32477
Drug Identification Number 02238525
Brand name HP-PAC
Common or Proper name LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN
Company Name TAKEDA PHARMACEUTICALS AMERICA INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) AMOXICILLIN LANSOPRAZOLE CLARITHROMYCIN
Strength(s) 500MG 30MG 500MG
Dosage form(s) KIT CAPSULE CAPSULE (SUSTAINED-RELEASE) TABLET
Route of administration ORAL
Packaging size Blister pack
ATC code A02BD
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2018-05-07
Estimated end date
Actual end date 2018-06-25
Shortage status Resolved
Updated date 2018-06-26
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 95 HAYDEN AVENUE
LEXINGTON, MASSACHUSETTS
UNITED STATES 02421
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v47 2018-06-26 English Compare
v46 2018-06-25 French Compare
v45 2018-06-25 English Compare
v44 2018-06-25 English Compare
v43 2018-05-29 French Compare
v42 2018-05-29 English Compare
v41 2018-05-11 French Compare
v40 2018-05-11 English Compare
v39 2018-05-08 English Compare
v38 2018-05-07 French Compare
v37 2018-05-07 English Compare
v36 2018-05-04 English Compare
v35 2018-05-03 French Compare
v34 2018-05-03 English Compare
v33 2018-05-03 English Compare
v32 2018-05-01 French Compare
v31 2018-05-01 English Compare
v30 2018-04-18 French Compare
v29 2018-04-18 English Compare
v28 2018-04-17 French Compare

Showing 1 to 20 of 47